Next Event: Tampa Bay Area, April 3, 2014 Click for additional information.
Washington D.C. Symposium in January was a great success. Pictured above, Dr. Srdan Verstovsek from MD Anderson was one of several featured speakers at the event. You can watch video of all of the featured speakers.
Additional Patient Education Events for 2014:
- May 22, San Mateo, CA
- June- To be Announced
- September- London
Learn about clinical trials currently in progress for
myelofibrosis (MF), essential thrombocythemia (ET) and polycythemia vera (PV).
- CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients Who Have Low Platelet Counts
- CTI PERSIST 1 Clinical Trial Continues to Enroll Patients for Efficacy and Safety of Pacritinib.
- NeoGenomics is the First Laboratory to Offer Calreticulin (CALR) Mutation Testing for the Diagnosis and Classification of Myeloproliferative Neoplasms
Get the latest news on MPN research, clinical trials, treatments, education, and advocacy.
- Attention MPN Researchers: The MPN Research Foundation and the Leukemia and Lymphoma Society call for research proposals. For details click here.
- Novartis announces positive Phase III study for Jakavi in patients with PV
- Proposed Revision of WHO Diagnostic Criteria for MPNs by Dr. Angela Fleischman.
- Video Discussion of a Genetic Mutation- CalR
- “MPN Updates” a New Source of MPN News for Physicians and Healthcare Teams
- MPN Fatigue On-Line Survey
Patient & Caregiver Support
Join with other patients to learn more about your disease and treatment options through an in-person or online support group. Many major cities throughout the United States and internationally host regular meetings.
Support group forming in Tampa Bay area, Florida. Contact Ann Brazeau at email@example.com.Learn More
Science Advisor: Ruben Mesa
Our scientific advisor is Dr. Ruben Mesa of the Mayo Clinic. Read his latest update:
Free Patient Info Pack
Give us your address and we’ll send you a free informational package in the mail. Your contact information will be kept strictly confidential.Sign Up Now
What is a myeloproliferative neoplasm?
MPNs are a group of rare blood cancers that overproduce blood cells in the bone marrow, and are caused by genetic mutations in the blood stem cells:
- Myelofibrosis is a rare bone marrow cancer. Bone marrow cells that produce blood cells develop and function abnormally resulting in fibrous scar tissue formation.
- Polycythemia Vera is a disorder in which the bone marrow makes too many red blood cells. It may also result in the production of too many other types of blood cells – white blood cells and platelets.
- Essential Thrombocythemia causes the body to produce too many blood platelets-thrombocytes. It can cause abnormal clotting or bleeding. The bone marrow makes too many platelet-forming cells or megakaryocytes, which release platelets into your blood.